company background image
0MJF logo

Ambu LSE:0MJF Stock Report

Last Price

DKK 102.05

Market Cap

DKK 26.9b

7D

-3.1%

1Y

-20.8%

Updated

24 May, 2025

Data

Company Financials +

0MJF Stock Overview

A medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. More details

0MJF fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance1/6
Financial Health6/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Ambu A/S Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ambu
Historical stock prices
Current Share PriceDKK 102.05
52 Week HighDKK 154.65
52 Week LowDKK 100.10
Beta1.28
1 Month Change-12.85%
3 Month Change-27.42%
1 Year Change-20.83%
3 Year Change17.43%
5 Year Change-54.81%
Change since IPO1,428.84%

Recent News & Updates

Recent updates

Shareholder Returns

0MJFGB Medical EquipmentGB Market
7D-3.1%0.4%0.2%
1Y-20.8%7.1%2.3%

Return vs Industry: 0MJF underperformed the UK Medical Equipment industry which returned 7.1% over the past year.

Return vs Market: 0MJF underperformed the UK Market which returned 2.3% over the past year.

Price Volatility

Is 0MJF's price volatile compared to industry and market?
0MJF volatility
0MJF Average Weekly Movement6.1%
Medical Equipment Industry Average Movement6.7%
Market Average Movement5.9%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market3.3%

Stable Share Price: 0MJF has not had significant price volatility in the past 3 months compared to the UK market.

Volatility Over Time: 0MJF's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19375,000Britt Jensenwww.ambu.com

Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Ambu A/S Fundamentals Summary

How do Ambu's earnings and revenue compare to its market cap?
0MJF fundamental statistics
Market capDKK 26.91b
Earnings (TTM)DKK 370.00m
Revenue (TTM)DKK 5.83b
72.7x
P/E Ratio
4.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0MJF income statement (TTM)
RevenueDKK 5.83b
Cost of RevenueDKK 2.32b
Gross ProfitDKK 3.52b
Other ExpensesDKK 3.15b
EarningsDKK 370.00m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 22, 2025

Earnings per share (EPS)1.39
Gross Margin60.27%
Net Profit Margin6.34%
Debt/Equity Ratio0%

How did 0MJF perform over the long term?

See historical performance and comparison

Dividends

0.4%
Current Dividend Yield
27%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/24 13:13
End of Day Share Price 2025/05/23 00:00
Earnings2025/03/31
Annual Earnings2024/09/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ambu A/S is covered by 19 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Michael HealyBerenberg
Alexander BerglundBofA Global Research